• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Professional Introduction to 2-TERT-BUTOXY-BENZONITRILE (CAS No: 218797-78-5)

2-TERT-BUTOXY-BENZONITRILE, with the chemical formula C₁₁H₁₃N and CAS number 218797-78-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and chemical synthesis. This compound belongs to the class of benzonitrile derivatives, characterized by a benzene ring substituted with a nitrile group and a tert-butyl ether moiety. The presence of the tert-butyl group enhances its stability and reactivity, making it a valuable intermediate in the development of various bioactive molecules.

The structure of 2-TERT-BUTOXY-BENZONITRILE plays a crucial role in its applications. The benzonitrile core is a versatile scaffold that can be further functionalized to produce pharmacologically active compounds. The tert-butyl ether side chain not only influences the electronic properties of the molecule but also contributes to its solubility and metabolic stability. These features make it an attractive candidate for drug design, particularly in the quest for novel therapeutics targeting neurological and inflammatory disorders.

In recent years, there has been growing interest in benzonitrile derivatives as potential candidates for medicinal chemistry. The nitrile group in these compounds can undergo various transformations, including hydrolysis to carboxylic acids or reduction to primary amines, which are key steps in synthesizing complex molecules. The 2-TERT-BUTOXY-BENZONITRILE molecule, with its unique substituents, offers a balance between reactivity and stability, making it suitable for diverse synthetic pathways.

One of the most compelling aspects of 2-TERT-BUTOXY-BENZONITRILE is its application in the synthesis of neuroprotective agents. Recent studies have demonstrated that benzonitrile derivatives can modulate neurotransmitter systems, potentially offering benefits in treating conditions such as Alzheimer's disease and Parkinson's disease. The tert-butyl ether group enhances blood-brain barrier penetration, which is critical for developing effective central nervous system (CNS) drugs. Researchers have been exploring its derivatives as potential cholinesterase inhibitors, which are known to improve cognitive function in patients with neurodegenerative diseases.

The pharmaceutical industry has also been investigating 2-TERT-BUTOXY-BENZONITRILE for its role in developing anti-inflammatory agents. Inflammatory processes are implicated in a wide range of diseases, including arthritis, cardiovascular disorders, and autoimmune conditions. The compound's ability to interact with various biological targets makes it a promising candidate for designing novel anti-inflammatory drugs. Preliminary studies suggest that derivatives of 2-TERT-BUTOXY-BENZONITRILE can inhibit key enzymes involved in inflammation, such as cyclooxygenase (COX) and lipoxygenase (LOX).

Another area where 2-TERT-BUTOXY-BENZONITRILE shows promise is in the development of anticancer agents. Cancer research has identified multiple pathways that contribute to tumor growth and progression. Benzonitrile derivatives have been shown to interfere with these pathways by inhibiting key enzymes and signaling molecules. The structural flexibility of 2-TERT-BUTOXY-BENZONITRILE allows chemists to modify its core structure to target specific cancer-related proteins. Some preliminary findings indicate that certain derivatives can induce apoptosis (programmed cell death) in cancer cells while sparing healthy cells.

The synthesis of 2-TERT-BUTOXY-BENZONITRILE involves well-established organic chemistry techniques, including nucleophilic substitution reactions and condensation reactions. The tert-butyl group is typically introduced via an etherification reaction, where benzonitrile reacts with tert-butanol under acidic or basic conditions. This method ensures high yield and purity, making it suitable for industrial-scale production. Advances in catalytic systems have further improved the efficiency of these reactions, reducing waste and energy consumption.

In terms of analytical characterization, 2-TERT-BUTOXY-BENZONITRILE can be readily identified using spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Proton NMR provides detailed information about the hydrogen environments in the molecule, while carbon NMR helps confirm the presence of the benzonitrile and tert-butyl ether groups. Mass spectrometry offers high sensitivity and specificity, allowing for accurate quantification even at low concentrations.

The chemical properties of 2-TERT-BUTOXY-BENZONITRILE make it an excellent candidate for further derivatization. Researchers have been exploring various functional groups that can be introduced into its structure to enhance its biological activity. For example, replacing the nitrile group with an amine or carboxylic acid moiety can lead to new pharmacophores with different therapeutic profiles. Such modifications are essential for optimizing drug candidates for clinical use.

The safety profile of 2-TERT-BUTOXY-BENZONITRILE is another critical consideration in pharmaceutical development. While preliminary studies suggest that it is relatively non-toxic at moderate doses, further research is needed to assess its long-term effects. Toxicological studies are being conducted to evaluate potential side effects and determine safe dosage ranges. These studies are essential for ensuring that any drug derived from this compound will be safe and effective for human use.

In conclusion, 2-TERT-BUTOXY-BENZONITRILE (CAS No: 218797-78-5) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and versatile reactivity. Its applications in neuroprotective agents, anti-inflammatory drugs, and anticancer therapies highlight its potential as a building block for novel therapeutics. As research continues to uncover new applications for this compound, 2-TERT-BUTOXY-BENZONITRILE is poised to play an increasingly important role in drug discovery and development.

• 548472-47-5(2-Isopropoxy-4-methoxybenzonitrile)
• 90921-35-0(2-Isopropoxy-benzonitrile)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)